Compositions and methods of using islet neogenesis peptides and analogs thereof
AssigneeShenzhen HighTide Biopharmaceutical, Ltd.
InventorsLiping Liu, Ru Bai
Life of this patent
Estimating the term…
Abstract
The invention provides peptides and analogs of INGAP and HIP peptides. The peptides and analogs can be used in methods for treating various diseases and conditions. Such diseases and conditions can include impaired pancreatic function, treating a metabolic disease, for example, diabetes, both type 1 and type 2 diabetes, islets induction, expansion and proliferation for transplantation, promoting neuroprotection or nerve regeneration, promoting liver regeneration or inhibiting inflammation.
Claims5
A method for promoting liver regeneration, comprising contacting a liver cell with a peptide or analog, wherein the peptide or analog consists of a peptide or analog selected from the group consisting of:
- (SEQ ID NO:
- 7)
- IGLHDPSHGTLPAGS;
- (SEQ ID NO:
- 73)
- IGLHDPSHGTLPAG;
- (SEQ ID NO:
- 50)
- IGLHDPTQGTEPAGE;
- (SEQ ID NO:
- 16)
- Ac-IGLHDPSHGTLPNGS;
- (SEQ ID NO:
- 17)
- (D-Ile)GLHDPSHGTLPNGS;
- (SEQ ID NO:
- 32)
- IGLHDPSHGTLPNGS-NH2;
- (SEQ ID NO:
- 33)
- IGLHDPSHGTLPNGSC;
- (SEQ ID NO:
- 34)
- Ac-IGLHDPSHGTLPNGSC;
- (SEQ ID NO:
- 35)
- IGLHDPSHGTLPNGSC-NH2;
- (SEQ ID NO:
- 36)
- Ac-IGLHDPSHGTLPNGSC-NH2;
- (SEQ ID NO:
- 37)
- IGLHDPSHGTLPNGC;
- (SEQ ID NO:
- 38)
- Ac-IGLHDPSHGTLPNGC;
- (SEQ ID NO:
- 39)
- IGLHDPSHGTLPNGC-NH2;
- (SEQ ID NO:
- 40)
- Ac-IGLHDPSHGTLPNGC-NH2;
- (SEQ ID NO:
- 75)
- Ac-IGLHDPSHGTLPNG;
- (SEQ ID NO:
- 76)
- IGLHDPSHGTLPNG-NH2;
- (SEQ ID NO:
- 77)
- Ac-IGLHDPSHGTLPNG-NH2;
- (SEQ ID NO:
- 54)
- Ac-IGLHDPTQGTEPNGE;
- (SEQ ID NO:
- 55)
- (D-Ile)GLHDPTQGTEPNGE;
- (SEQ ID NO:
- 61)
- Ac-IGLHDPTQGTEPNGE-NH2;
- (SEQ ID NO:
- 63)
- IGLHDPTQGTEPNGE-NH2;
- (SEQ ID NO:
- 64)
- IGLHDPTQGTEPNGC;
- (SEQ ID NO:
- 65)
- Ac-IGLHDPTQGTEPNGC;
- (SEQ ID NO:
- 66)
- IGLHDPTQGTEPNGC-NH2;
- (SEQ ID NO:
- 67)
- Ac-IGLHDPTQGTEPNGC-NH2;
- (SEQ ID NO:
- 6)
- IGLHAPSHGTLPNGS;
- (SEQ ID NO:
- 8)
- IGLHAPSHGTLPAGS;
- (SEQ ID NO:
- 18)
- IGLHDPSHGTEPNGS;
- (SEQ ID NO:
- 19)
- IGLHDPSQGTLPNGS;
- (SEQ ID NO:
- 20)
- IGLHDPTHGTLPNGS;
- (SEQ ID NO:
- 21)
- IGLHDPSHGTLPNGE;
- (SEQ ID NO:
- 22)
- IGLHDPSHGTLPNGK;
- (SEQ ID NO:
- 23)
- IGLHDPSHGTLPAGK;
- (SEQ ID NO:
- 24)
- IGLHDPSHGTEPAGS;
- (SEQ ID NO:
- 25)
- IGLHDPSQGTLPAGS;
- (SEQ ID NO:
- 26)
- IGLHDPTHGTLPAGS;
- (SEQ ID NO:
- 27)
- IGLHDPSHGTLPAGE;
- (SEQ ID NO:
- 56)
- IGLHDPTQGTEPNGS;
- (SEQ ID NO:
- 57)
- IGLHDPTQGTEPAGS;
- (SEQ ID NO:
- 58)
- IGLHDPTQGTLPNGE;
- and
- (SEQ ID NO:
- 59)
- IGLHDPTQGTLPAGE.
Dependencies are inferred from the claim text.